Versant Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.4K | Buy |
|
|||||
|
2025
Q2 | $18K | Buy |
|
|||||
|
2025
Q1 | $9.73K | Buy |
|
|||||
|
2024
Q4 | $4.14K | Hold |
|
|||||
|
2024
Q3 | $5.91K | Buy |
|
|||||
|
2024
Q2 | $2.35K | Sell |
|
|||||
|
2024
Q1 | $2.24K | Buy |
|
|||||
|
2023
Q4 | $172 | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $531 | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $0 | Buy |
|